Comparative effectiveness of disease-modifying antirheumatic drugs for patients with cardiac sarcoidosis
A strategy of methotrexate had a favorable safety profile in terms of infection risk and may be favored over azathioprine or mycophenolate mofetil for patients with sarcoidosis or cardiac sarcoidosis.
Authors
- L. Brooks (ORCID: https://orcid.org/0009-0007-6442-870X)
- Michael Putman (ORCID: https://orcid.org/0000-0001-9699-4000)
- Divyanshu Mohananey (ORCID: https://orcid.org/0000-0003-2815-2949)
- Viktoriya Sabchyshyn
- William Kivlin
Institutions
- Medical College of Wisconsin (US)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2024-12-26
- DOI
- https://doi.org/10.1093/rheumatology/keae692
- Citations
- 4
- Primary Topic
- Sarcoidosis and Beryllium Toxicity Research
- Type
- article
- Field-Weighted Citation Impact
- 1.31
Funders
- Rheumatology Research Foundation
- National Institutes of Health
- National Heart, Lung, and Blood Institute